{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:32:47Z","timestamp":1760056367303,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.diagmicrobio.2022.115881","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T02:45:17Z","timestamp":1671072317000},"page":"115881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improved disk diffusion method for simple detection of group B streptococci with reduced penicillin susceptibility (PRGBS)"],"prefix":"10.1016","volume":"105","author":[{"given":"Rikuko","family":"Goto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanchun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Wachino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshichika","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0001","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/cid\/cit337","article-title":"Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010","volume":"57","author":"Lamagni","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0002","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","article-title":"Active Bacterial Core surveillance\/Emerging Infections Program Network. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005","volume":"299","author":"Phares","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0003","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1093\/cid\/ciu514","article-title":"neoMen Study Group. Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United Kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance","volume":"59","author":"Okike","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(98)07128-1","article-title":"Group B Streptococcus","volume":"353","author":"Schuchat","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0005","first-page":"1","article-title":"Prevention of perinatal group B Streptococcal disease. Revised guidelines from CDC","volume":"51","author":"Schrag","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0006","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/AAC.00185-08","article-title":"First molecular characterization of group B Streptococci with reduced penicillin susceptibility","volume":"52","author":"Kimura","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0007","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1128\/AAC.00596-08","article-title":"Genetic heterogeneity in pbp genes among clinically isolated group B streptococci with reduced penicillin susceptibility","volume":"52","author":"Nagano","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0008","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1128\/AAC.01716-08","article-title":"Invasive Streptococcal Disease Working Group. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections","volume":"53","author":"Murayama","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0009","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1128\/AAC.00461-08","article-title":"Point mutation in the group B Streptococcal pbp2x gene conferring decreased susceptibility to \u03b2-lactam antibiotics","volume":"52","author":"Dahesh","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0010","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.cmi.2017.02.021","article-title":"Active Bacterial Core surveillance team. Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA","volume":"23","author":"Metcalf","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0011","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jac\/dkp458","article-title":"Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone","volume":"65","author":"Gaudreau","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0012","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/AAC.01243-10","article-title":"Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy","volume":"55","author":"Longtin","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0013","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/jac\/dkz465","article-title":"Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany","volume":"75","author":"van der Linden","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191193","article-title":"Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015","volume":"13","author":"Siga\u00faque","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0015","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1089\/mdr.2017.0223","article-title":"New mutations of penicillin-binding proteins in Streptococcus agalactiae isolates from cattle with decreased susceptibility to penicillin","volume":"24","author":"Hu","year":"2018","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0016","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/microorganisms8071055","article-title":"Multidrug-resistant Streptococcus agalactiae strains found in human and fish with high penicillin and cefotaxime non-susceptibilities","volume":"8","author":"Li","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0017","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3343\/alm.2019.39.4.414","article-title":"First case in Korea of group B Streptococcus with reduced penicillin susceptibility harboring amino acid substitutions in penicillin-binding protein 2X","volume":"39","author":"Yi","year":"2019","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0018","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jac\/dks423","article-title":"High frequency of fluoroquinolone- and macrolide-resistant streptococci among clinically isolated group B streptococci with reduced penicillin susceptibility","volume":"68","author":"Kimura","year":"2013","journal-title":"J Antimicrob Chemother"},{"year":"2020","series-title":"Performance standards for antimicrobial susceptibility testing; 30th informational supplement","key":"10.1016\/j.diagmicrobio.2022.115881_bib0019"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0020","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/jac\/dkt008","article-title":"Ability of the VITEK\u00ae 2 system to detect group B streptococci with reduced penicillin susceptibility (PRGBS)","volume":"68","author":"Kimura","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0021","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1128\/JCM.02063-08","article-title":"Practical disk diffusion test for detecting group B Streptococcus with reduced penicillin susceptibility","volume":"47","author":"Kimura","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0022","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diagmicrobio.2016.04.018","article-title":"Effectual detection of group B streptococci with reduced penicillin susceptibility (PRGBS) by commercially available methicillin-resistant-Staphylococcus aureus (MRSA)-selective agar","volume":"85","author":"Fukigai","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115881_bib0023","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1128\/JCM.01291-14","article-title":"Penicillin-susceptible group B streptococcal clinical isolates with reduced cephalosporin susceptibility","volume":"52","author":"Nagano","year":"2014","journal-title":"J Clin Microbiol"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889322002450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889322002450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:58:15Z","timestamp":1760003895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889322002450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0732889322002450"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115881","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved disk diffusion method for simple detection of group B streptococci with reduced penicillin susceptibility (PRGBS)","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115881"}}